Skip to content
Home » Co-Innovation


Cell And Gene Therapy Market Potential: Co-Innovation - Hugues Joublin

Cell And Gene Therapy Market Potential: Co-Innovation – Hugues Joublin

As a pharma or family caregiver, you know that cell and gene therapies have the potential to treat some of the most complex health conditions with unprecedented accuracy. However, one major challenge still remains: how to unlock that market potential within an ever-evolving regulatory landscape? The answer lies in co-innovation—collaborating with fellow scientists, government agencies, and industry partners on the development of safety protocols and value-based healthcare strategies. By harnessing collective power to research emerging technologies, share knowledge and develop breakthroughs together, we can ensure these life-saving treatments reach their full potential. In this blog post, Hugues Joublin discusses how co-innovation can make all the difference when unlocking cell and gene therapy’s vast market potential. Hugues Joublin On How Co-Innovation Can Unlock Cell And Gene Therapy Market Potential The potential of cell and gene therapy to revolutionize healthcare is immense, says Hugues Joublin, but the market for these therapies remains challenging. The high cost of research and development, lack of regulatory guidance, and access to capital have limited progress. Co-innovation can be an effective way to overcome some of these challenges by creating partnerships between stakeholders across industry, government, and academia. Co-innovation involves collaboration between different parties in order to create innovative solutions that would normally be difficult or impossible to achieve on their own. This approach brings together diverse perspectives, expertise, and resources, which… Read More »Cell And Gene Therapy Market Potential: Co-Innovation – Hugues Joublin